Cargando…
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
Hepatocellular carcinoma (HCC) is a hypervascular malignancy and is the third leading cause of death worldwide. The disease has multiple predisposing risk factors and limited treatment options. Although the precise mechanism(s) underlying HCC is unknown, several pathways have been implicated in its...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211614/ https://www.ncbi.nlm.nih.gov/pubmed/25364263 http://dx.doi.org/10.2147/OTT.S46457 |